Clinical trial
Randomised Controlled Prospective Trial of Early Administration of Aspirin After Systemic Thrombolysis in Acute Ischemic Stroke
NCT02921360 is registered in ClinicalTrials.gov with City Clinical Hospital No. 67, Moscow, Russia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomised Controlled Prospective Trial of Early Administration of Aspirin After Systemic Thrombolysis in Acute Ischemic Stroke
- Lead sponsor
- City Clinical Hospital No. 67, Moscow, Russia
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- August 31, 2016
- Completion date
- Not reported
- Enrollment
- 120 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.